OBJECTIVE: Hyperhomocysteinemia, neurohormonal activation, inflammation and altered fibrinolysis have been linked to atherothrombosis as well as to myocardial fibrosis and heart failure. Hence, we related a panel of biomarkers representing these pathways to plasma markers of collagen metabolism in a large community-based sample. METHODS: We related nine biomarkers representing select biologic pathways (independent variables: C-reactive protein, B-type natriuretic peptide, N-terminal proatrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen activator inhibitor-1 and homocysteine) to three plasma markers of collagen turnover [dependent variables, separate models for each: aminoterminal propeptide of type III collagen, tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-9 (present versus absent)] in 921 Framingham Heart study participants (mean age 57 years; 58% women). Participants were separated a priori into those with left ventricular end-diastolic dimensions and wall thickness below sex-specific median values (referent group) and either measure at least 90th sex-specific percentile ('remodeled' group). We used stepwise multivariable regression analysis adjusting for cardiovascular risk factors to relate the panel of systemic biomarkers to the three biomarkers of collagen metabolism. RESULTS: Plasma homocysteine was positively related to all three markers of collagen metabolism in the remodeled group and to aminoterminal propeptide of type III collagen and tissue inhibitor of metalloproteinases-1 in the referent group. Plasminogen activator inhibitor-1 was positively related to aminoterminal propeptide of type III collagen and tissue inhibitor of metalloproteinases-1 in both groups, whereas the natriuretic peptides were associated positively with these collagen markers in the referent group. CONCLUSION: In our large community-based sample, plasma homocysteine and plasminogen activator inhibitor-1 were positively related to circulating collagen biomarkers, consistent with experimental studies implicating these pathways in cardiovascular collagen turnover.
OBJECTIVE:Hyperhomocysteinemia, neurohormonal activation, inflammation and altered fibrinolysis have been linked to atherothrombosis as well as to myocardial fibrosis and heart failure. Hence, we related a panel of biomarkers representing these pathways to plasma markers of collagen metabolism in a large community-based sample. METHODS: We related nine biomarkers representing select biologic pathways (independent variables: C-reactive protein, B-type natriuretic peptide, N-terminal proatrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen activator inhibitor-1 and homocysteine) to three plasma markers of collagen turnover [dependent variables, separate models for each: aminoterminal propeptide of type III collagen, tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-9 (present versus absent)] in 921 Framingham Heart study participants (mean age 57 years; 58% women). Participants were separated a priori into those with left ventricular end-diastolic dimensions and wall thickness below sex-specific median values (referent group) and either measure at least 90th sex-specific percentile ('remodeled' group). We used stepwise multivariable regression analysis adjusting for cardiovascular risk factors to relate the panel of systemic biomarkers to the three biomarkers of collagen metabolism. RESULTS: Plasma homocysteine was positively related to all three markers of collagen metabolism in the remodeled group and to aminoterminal propeptide of type III collagen and tissue inhibitor of metalloproteinases-1 in the referent group. Plasminogen activator inhibitor-1 was positively related to aminoterminal propeptide of type III collagen and tissue inhibitor of metalloproteinases-1 in both groups, whereas the natriuretic peptides were associated positively with these collagen markers in the referent group. CONCLUSION: In our large community-based sample, plasma homocysteine and plasminogen activator inhibitor-1 were positively related to circulating collagen biomarkers, consistent with experimental studies implicating these pathways in cardiovascular collagen turnover.
Authors: Jacob Joseph; Lija Joseph; Nawal S Shekhawat; Sulochana Devi; Junru Wang; Russell B Melchert; Martin Hauer-Jensen; Richard H Kennedy Journal: Am J Physiol Heart Circ Physiol Date: 2003-05-01 Impact factor: 4.733
Authors: Ramachandran S Vasan; Jane C Evans; Emelia J Benjamin; Daniel Levy; Martin G Larson; Johan Sundstrom; Joanne M Murabito; Flora Sam; Wilson S Colucci; Peter W F Wilson Journal: Hypertension Date: 2004-03-08 Impact factor: 10.190
Authors: Johan Sundström; Jane C Evans; Emelia J Benjamin; Daniel Levy; Martin G Larson; Douglas B Sawyer; Deborah A Siwik; Wilson S Colucci; Peter W F Wilson; Ramachandran S Vasan Journal: Eur Heart J Date: 2004-09 Impact factor: 29.983
Authors: Johan Sundström; Jane C Evans; Emelia J Benjamin; Daniel Levy; Martin G Larson; Douglas B Sawyer; Deborah A Siwik; Wilson S Colucci; Patrice Sutherland; Peter W F Wilson; Ramachandran S Vasan Journal: Circulation Date: 2004-06-01 Impact factor: 29.690
Authors: Ernest Walker; Jason Black; Cordel Parris; Elizabeth C Bryda; Silvestre Cansino; Lisa Hunt; Jean Chappell; Paulette Wehner; Mark Studeny; Gary L Wright Journal: Ann Clin Lab Sci Date: 2004 Impact factor: 1.256
Authors: Jarkko Magga; Mikko Puhakka; Seppo Hietakorpi; Kari Punnonen; Paavo Uusimaa; Juha Risteli; Olli Vuolteenaho; Heikki Ruskoaho; Keijo Peuhkurinen Journal: J Appl Physiol (1985) Date: 2003-11-07
Authors: Ramachandran S Vasan; Alexa Beiser; Ralph B D'Agostino; Daniel Levy; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Peter W F Wilson Journal: JAMA Date: 2003-03-12 Impact factor: 56.272
Authors: J Orbe; L Fernandez; J A Rodríguez; G Rábago; M Belzunce; A Monasterio; C Roncal; José A Páramo Journal: Atherosclerosis Date: 2003-10 Impact factor: 5.162
Authors: Johan Sundström; Lisa Sullivan; Jacob Selhub; Emelia J Benjamin; Ralph B D'Agostino; Paul F Jacques; Irwin H Rosenberg; Daniel Levy; Peter W F Wilson; Ramachandran S Vasan Journal: Eur Heart J Date: 2004-03 Impact factor: 29.983
Authors: Raghava S Velagaleti; Philimon Gona; Johan Sundström; Martin G Larson; Deborah Siwik; Wilson S Colucci; Emelia J Benjamin; Ramachandran S Vasan Journal: Arterioscler Thromb Vasc Biol Date: 2010-08-26 Impact factor: 8.311
Authors: Mateus D Marques; Victor Nauffal; Bharath Ambale-Venkatesh; Henrique D Vasconcellos; Colin Wu; Hossein Bahrami; Russell P Tracy; Mary Cushman; David A Bluemke; João A C Lima Journal: Hypertension Date: 2018-10 Impact factor: 10.190